A phase II trial of biweekly vinorelbine and oxaliplatin in second- or third-line metastatic triple-negative breast cancer.
about
Phase I/Ib study of olaparib and carboplatin in women with triple negative breast cancer.Novel insight into triple-negative breast cancers, the emerging role of angiogenesis, and antiangiogenic therapy.Alterations of Signaling Pathways Related to the Immune System in Breast Cancer: New Perspectives in Patient Management
P2860
A phase II trial of biweekly vinorelbine and oxaliplatin in second- or third-line metastatic triple-negative breast cancer.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A phase II trial of biweekly v ...... triple-negative breast cancer.
@ast
A phase II trial of biweekly v ...... triple-negative breast cancer.
@en
type
label
A phase II trial of biweekly v ...... triple-negative breast cancer.
@ast
A phase II trial of biweekly v ...... triple-negative breast cancer.
@en
prefLabel
A phase II trial of biweekly v ...... triple-negative breast cancer.
@ast
A phase II trial of biweekly v ...... triple-negative breast cancer.
@en
P2093
P2860
P1476
A phase II trial of biweekly v ...... triple-negative breast cancer.
@en
P2093
Biyun Wang
Chunlei Zhen
Fangfang Lv
Jian Zhang
Leiping Wang
Sheng Zhang
Zhimin Shao
Zhonghua Wang
P2860
P304
P356
10.4161/15384047.2014.986973
P577
2015-01-01T00:00:00Z